Healthcare provider Benenden Health has reported a £25.1m operational surplus last year, which it intends to use to deliver new products for its more than 870,000 members.
The not-for-profit continued to invest in their services during 2025 adding 80 new surgical procedures across areas such as gynaecology, urology and ear, nose and throat.
Benenden also invested in its digital services, which includes an app-based heart monitor, eye screening, skin cancer detection and a remote dermatology service.
The surplus was the result of lower claim costs for surgery and GP appointments. An investment in technology and enhancing its products were also factors.
Benenden’s chief executive, Tom Woolgrove (pictured), said that moving from a deficit to a £25m surplus in just two years is a significant achievement, which gives the company a platform to invest more in its services.
“This surplus has enabled us to expand our product in meaningful ways, from adding 80 new surgical procedures to introducing new digital health tools that help members monitor their heart, eye and skin health.
“These enhancements are all about giving all members more value and more ways to take control of their health and wellbeing.
“As we enter 2026, we’re focused on using this strong financial footing to deliver new products, improve member experience and ensure Benenden Health remains the UK’s leading affordable healthcare provider.”
